Mara Artibani

Latest

• The Oxford Classic can identify HGSOC patients who may benefit from EMT-targeting therapies
• Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
• Promises and challenges of adoptive T-cell therapies for solid tumours
• The Oxford classic links epithelial-to-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers
• A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes
• The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells
• Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies